{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-033265","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2024-08-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.821377+00:00","generated_at":"2026-05-31T08:28:27.521163+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Evofem and Aditxt amend merger, extend third equity investment deadline contingent on Aditxt raising $20M","bullets":["Third Parent Equity Investment deadline moved to earlier of Sep 6, 2024 or 5 business days after Aditxt closes a ≥$20M public offering.","Aditxt must purchase 2,000 shares of Evofem Series F-1 Preferred for $2,000,000 on that date.","Other investment dates unchanged: $500k (Jul 12), $500k (Aug 9), $1,000k (Sep 30).","Amendment signed Aug 16, 2024 by CEOs of Evofem (Saundra Pelletier) and Aditxt (Amro Albanna)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-033265","json":"https://secwatch.observer/filing/0001493152-24-033265.json","markdown":"https://secwatch.observer/filing/0001493152-24-033265.md","text":"https://secwatch.observer/filing/0001493152-24-033265.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224033265/0001493152-24-033265-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224033265/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:28:27.521163+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}